This Article Full Text (PDF) All Versions of this Article: 0269881107077609v1 21/8/857    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sarandol, A. Articles by Sarandol, E. Search for Related Content PubMed PubMed Citation Articles by Sarandol, A. Articles by Sarandol, E. Social Bookmarking                   What's this?

Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment

Department of Psychiatry, Uludag University Medical Faculty, Bursa, Turkey, asli{at}uludag.edu.tr

Selcuk Kirli

Department of Psychiatry, Uludag University Medical Faculty, Bursa, Turkey

Cengiz Akkaya

Department of Psychiatry, Uludag University Medical Faculty, Bursa, Turkey

Nihal Ocak

Department of Psychiatry, Uludag University Medical Faculty, Bursa, Turkey

Esma Eroz

Department of Psychiatry, Uludag University Medical Faculty, Bursa, Turkey

Emre Sarandol

Department of Psychiatry, Uludag University Medical Faculty, Bursa, Turkey

The aim of the present study was to investigate serum paraoxonase/arylesterase activities and oxidation/oxidizability of apolipoprotein B-containing lipoproteins and several coronary artery disease risk factors, including homocysteine, high sensitive C-reactive protein, tumour necrosis factor-, leptin and adiponectin in patients with schizophrenia. Oxidation of lipoproteins plays an important role in atherogenesis, and the enzyme paraoxonase has been shown to prevent lipoprotein oxidation. Furthermore, low paraoxonase activity has been suggested to predict coronary artery disease. Forty patients who fully met the fourth Diagnostic and Statistical Manual of Mental Disorders criteria for schizophrenia and 35 healthy control subjects were included in the study. Serum paraoxonase/arylesterase activities were determined spectrophotometrically. Malondialdehyde levels of apolipoprotein B-containing lipoproteins were determined before and after incubation with copper-sulphate, which yielded basal- and -malondialdehyde values, respectively. Homocysteine and highly sensitive C-reactive protein levels were determined using a fluorescence-polarization immunoassay and immunonephelometry, respectively. Leptin and adiponectin levels were measured with radioimmunoassay and tumour necrosis factor- was determined by enzyme linked immunosorbent assay. Serum paraoxonase and arylesterase activities were significantly lower and -malondialdehyde levels were significantly higher in the schizophrenia group compared with the control group. However, there were not any significant differences in other parameters of the study between the study groups. There was a significant increase in body mass index and serum triglyceride and very low density lipoprotein cholesterol levels in the schizophrenic group after 6 weeks of treatment. These parameters were significantly increased in patients treated with atypical antipsychotics but not in patients treated with typic or long acting antipsychotics. The results of the present study suggest that patients with schizophrenia might have increased risk for coronary artery disease related to reduced serum paraoxonase activity and increased oxidizability of apolipoprotein B-containing lipoproteins.

Key Words: adiponectin • antipsychotic • high sensitive C-reactive protein • homocysteine • leptin • lipoprotein oxidation • paraoxonase • schizophrenia • tumour necrosis factor-

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?